Signal	NN	B-NP	O	Other	Other	###	1	Signal	Signal	NN	NN	_	3	compound	_	_
transduction	NN	I-NP	O	Other	Other	###	2	transduction	transduction	NN	NN	_	3	compound	_	_
abnormalities	NNS	I-NP	O	Other	Other	###	3	abnormalities	abnormalities	NNS	NNS	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	4	in	in	IN	IN	_	6	case	_	_
T	NN	B-NP	B-cell_type	Other	Other	###	5	T	T	NN	NN	_	6	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	Other	###	6	lymphocytes	lymphocytes	NNS	NNS	_	3	nmod	_	_
from	IN	B-PP	O	Other	Other	###	7	from	from	IN	IN	_	8	case	_	_
patients	NNS	B-NP	O	Other	Other	###	8	patients	patients	NNS	NNS	_	6	nmod	_	_
with	IN	B-PP	O	Other	Other	###	9	with	with	IN	IN	_	12	case	_	_
advanced	VBN	B-NP	O	Other	Other	###	10	advanced	advanced	VBN	VBN	_	12	amod	_	_
renal	JJ	I-NP	O	Other	Other	###	11	renal	renal	JJ	JJ	_	12	amod	_	_
carcinoma	NN	I-NP	O	Other	Other	###	12	carcinoma	carcinoma	NN	NN	_	8	nmod	_	_
:	:	O	O	Other	Other	###	13	:	:	:	:	_	3	punct	_	_
clinical	JJ	B-NP	O	Other	Other	###	14	clinical	clinical	JJ	JJ	_	15	amod	_	_
relevance	NN	I-NP	O	Other	Other	###	15	relevance	relevance	NN	NN	_	3	dep	_	_
and	CC	O	O	Other	Other	###	16	and	and	CC	CC	_	15	cc	_	_
effects	NNS	B-NP	O	Other	Other	###	17	effects	effects	NNS	NNS	_	15	conj	_	_
of	IN	B-PP	O	Other	Other	###	18	of	of	IN	IN	_	20	case	_	_
cytokine	NN	B-NP	B-protein	Other	Other	###	19	cytokine	cytokine	NN	NN	_	20	compound	_	_
therapy	NN	I-NP	O	Other	Other	###	20	therapy	therapy	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	Other	###	21	.	.	.	.	_	3	punct	_	_

Studies	NNS	B-NP	O	Other	Other	###	1	Studies	Studies	NNS	NNS	_	3	nsubj	_	_
have	VBP	B-VP	O	Other	Other	###	2	have	have	VBP	VBP	_	3	aux	_	_
demonstrated	VBN	I-VP	O	Other	Other	###	3	demonstrated	demonstrated	VBN	VBN	_	0	root	_	_
abnormalities	NNS	B-NP	O	Other	Other	###	4	abnormalities	abnormalities	NNS	NNS	_	3	dobj	_	_
of	IN	B-PP	O	Other	Other	###	5	of	of	IN	IN	_	7	case	_	_
the	DT	B-NP	O	Other	Other	###	6	the	the	DT	DT	_	7	det	_	_
CD3	NN	I-NP	B-protein	Other	Other	###	7	CD3	CD3	NN	NN	_	4	nmod	_	_
/	/	O	O	Other	Other	###	8	/	/	/	/	_	7	punct	_	_
T-cell	NN	I-NP	B-protein	Other	Other	###	9	T-cell	T-cell	NN	NN	_	11	compound	_	_
antigen	NN	I-NP	I-protein	Other	Other	###	10	antigen	antigen	NN	NN	_	11	compound	_	_
receptor	NN	I-NP	I-protein	Other	Other	###	11	receptor	receptor	NN	NN	_	7	dep	_	_
(	(	O	O	Other	Other	###	12	(	(	(	(	_	13	punct	_	_
TCR	NN	B-NP	B-protein	Other	Other	###	13	TCR	TCR	NN	NN	_	11	appos	_	_
)	)	O	O	Other	Other	###	14	)	)	)	)	_	13	punct	_	_
and	CC	O	O	Other	Other	###	15	and	and	CC	CC	_	4	cc	_	_
pathways	NNS	B-NP	O	Other	Other	###	16	pathways	pathways	NNS	NNS	_	4	conj	_	_
of	IN	B-PP	O	Other	Other	###	17	of	of	IN	IN	_	19	case	_	_
signal	NN	B-NP	O	Other	Other	###	18	signal	signal	NN	NN	_	19	compound	_	_
transduction	NN	I-NP	O	Other	Other	###	19	transduction	transduction	NN	NN	_	16	nmod	_	_
in	IN	B-PP	O	Other	Other	###	20	in	in	IN	IN	_	22	case	_	_
T	NN	B-NP	B-cell_type	Other	Other	###	21	T	T	NN	NN	_	22	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	Other	###	22	lymphocytes	lymphocytes	NNS	NNS	_	16	nmod	_	_
from	IN	B-PP	O	Other	Other	###	23	from	from	IN	IN	_	24	case	_	_
animals	NNS	B-NP	O	Other	Other	###	24	animals	animals	NNS	NNS	_	22	nmod	_	_
and	CC	O	O	Other	Other	###	25	and	and	CC	CC	_	24	cc	_	_
patients	NNS	B-NP	O	Other	Other	###	26	patients	patients	NNS	NNS	_	24	conj	_	_
with	IN	B-PP	O	Other	Other	###	27	with	with	IN	IN	_	29	case	_	_
advanced	JJ	B-NP	O	Other	Other	###	28	advanced	advanced	JJ	JJ	_	29	amod	_	_
malignancy	NN	I-NP	O	Other	Other	###	29	malignancy	malignancy	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	Other	###	30	.	.	.	.	_	3	punct	_	_

Diminished	VBN	B-NP	O	Other	Other	###	1	Diminished	Diminished	VBN	VBN	_	2	amod	_	_
expression	NN	I-NP	O	Other	Other	###	2	expression	expression	NN	NN	_	29	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	Other	###	4	TCRzeta	TCRzeta	NN	NN	_	2	nmod	_	_
and	CC	O	O	Other	Other	###	5	and	and	CC	CC	_	4	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	Other	###	6	p56(lck)	p56(lck)	NN	NN	_	4	conj	_	_
that	WDT	B-NP	O	Other	Other	###	7	that	that	WDT	WDT	_	9	nsubjpass	_	_
are	VBP	B-VP	O	Other	Other	###	8	are	are	VBP	VBP	_	9	auxpass	_	_
associated	VBN	I-VP	O	Other	Other	###	9	associated	associated	VBN	VBN	_	2	acl:relcl	_	_
with	IN	B-PP	O	Other	Other	###	10	with	with	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	Other	###	11	the	the	DT	DT	_	12	det	_	_
TCR	NN	I-NP	B-protein	Other	Other	###	12	TCR	TCR	NN	NN	_	9	nmod	_	_
and	CC	O	O	Other	Other	###	13	and	and	CC	CC	_	2	cc	_	_
reduced	VBN	B-NP	O	Other	Other	###	14	reduced	reduced	VBN	VBN	_	16	amod	_	_
nuclear	JJ	I-NP	O	Other	Other	###	15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
localization	NN	I-NP	O	Other	Other	###	16	localization	localization	NN	NN	_	2	conj	_	_
of	IN	B-PP	O	Other	Other	###	17	of	of	IN	IN	_	26	case	_	_
RelA	NN	B-NP	B-protein	B-Protein	Other	###	18	RelA	RelA	NN	NN	_	26	compound	_	_
containing	VBG	B-VP	O	Other	Other	###	19	containing	containing	VBG	VBG	_	26	amod	_	_
nuclear	JJ	B-NP	B-protein	Other	Other	###	20	nuclear	nuclear	JJ	JJ	_	26	amod	_	_
factor	NN	I-NP	I-protein	Other	Other	###	21	factor	factor	NN	NN	_	26	compound	_	_
kappaB	NN	I-NP	I-protein	Other	Other	###	22	kappaB	kappaB	NN	NN	_	26	compound	_	_
(	(	O	O	Other	Other	###	23	(	(	(	(	_	26	punct	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	24	NFkappaB	NFkappaB	NN	NN	_	26	compound	_	_
)	)	O	O	Other	Other	###	25	)	)	)	)	_	26	punct	_	_
complexes	NNS	B-NP	O	Other	Other	###	26	complexes	complexes	NNS	NNS	_	16	nmod	_	_
have	VBP	B-VP	O	Other	Other	###	27	have	have	VBP	VBP	_	29	aux	_	_
been	VBN	I-VP	O	Other	Other	###	28	been	been	VBN	VBN	_	29	auxpass	_	_
noted	VBN	I-VP	O	Other	Other	###	29	noted	noted	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	Other	###	30	.	.	.	.	_	29	punct	_	_

These	DT	B-NP	O	Other	Other	###	1	These	These	DT	DT	_	2	det	_	_
defects	NNS	I-NP	O	Other	Other	###	2	defects	defects	NNS	NNS	_	5	nsubjpass	_	_
have	VBP	B-VP	O	Other	Other	###	3	have	have	VBP	VBP	_	5	aux	_	_
been	VBN	I-VP	O	Other	Other	###	4	been	been	VBN	VBN	_	5	auxpass	_	_
described	VBN	I-VP	O	Other	Other	###	5	described	described	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	6	in	in	IN	IN	_	8	case	_	_
T	NN	B-NP	B-cell_type	Other	Other	###	7	T	T	NN	NN	_	8	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	8	cells	cells	NNS	NNS	_	5	nmod	_	_
from	IN	B-PP	O	Other	Other	###	9	from	from	IN	IN	_	10	case	_	_
patients	NNS	B-NP	O	Other	Other	###	10	patients	patients	NNS	NNS	_	8	nmod	_	_
with	IN	B-PP	O	Other	Other	###	11	with	with	IN	IN	_	13	case	_	_
malignant	JJ	B-NP	O	Other	Other	###	12	malignant	malignant	JJ	JJ	_	13	amod	_	_
melanoma	NN	I-NP	O	Other	Other	###	13	melanoma	melanoma	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	Other	###	14	,	,	,	,	_	13	punct	_	_
renal	JJ	B-NP	O	Other	Other	###	15	renal	renal	JJ	JJ	_	17	amod	_	_
cell	NN	I-NP	O	Other	Other	###	16	cell	cell	NN	NN	_	17	compound	_	_
carcinoma	NN	I-NP	O	Other	Other	###	17	carcinoma	carcinoma	NN	NN	_	13	conj	_	_
(	(	O	O	Other	Other	###	18	(	(	(	(	_	19	punct	_	_
RCC	NN	B-NP	O	Other	Other	###	19	RCC	RCC	NN	NN	_	17	appos	_	_
)	)	O	O	Other	Other	###	20	)	)	)	)	_	19	punct	_	_
,	,	O	O	Other	Other	###	21	,	,	,	,	_	13	punct	_	_
ovarian	JJ	B-NP	O	Other	Other	###	22	ovarian	ovarian	JJ	JJ	_	23	amod	_	_
cancer	NN	I-NP	O	Other	Other	###	23	cancer	cancer	NN	NN	_	13	conj	_	_
,	,	O	O	Other	Other	###	24	,	,	,	,	_	13	punct	_	_
and	CC	O	O	Other	Other	###	25	and	and	CC	CC	_	13	cc	_	_
colorectal	JJ	B-NP	O	Other	Other	###	26	colorectal	colorectal	JJ	JJ	_	27	amod	_	_
cancer	NN	I-NP	O	Other	Other	###	27	cancer	cancer	NN	NN	_	13	conj	_	_
.	.	O	O	Other	Other	###	28	.	.	.	.	_	5	punct	_	_

Preliminary	JJ	B-NP	O	Other	Other	###	1	Preliminary	Preliminary	JJ	JJ	_	2	amod	_	_
observations	NNS	I-NP	O	Other	Other	###	2	observations	observations	NNS	NNS	_	4	nsubj	_	_
also	RB	B-ADVP	O	Other	Other	###	3	also	also	RB	RB	_	4	advmod	_	_
indicate	VBP	B-VP	O	Other	Other	###	4	indicate	indicate	VBP	VBP	_	0	root	_	_
possible	JJ	B-NP	O	Other	Other	###	5	possible	possible	JJ	JJ	_	6	amod	_	_
correlation	NN	I-NP	O	Other	Other	###	6	correlation	correlation	NN	NN	_	4	dobj	_	_
with	IN	B-PP	O	Other	Other	###	7	with	with	IN	IN	_	9	case	_	_
clinical	JJ	B-NP	O	Other	Other	###	8	clinical	clinical	JJ	JJ	_	9	amod	_	_
variables	NNS	I-NP	O	Other	Other	###	9	variables	variables	NNS	NNS	_	6	nmod	_	_
such	JJ	B-PP	O	Other	Other	###	10	such	such	JJ	JJ	_	12	case	_	_
as	IN	I-PP	O	Other	Other	###	11	as	as	IN	IN	_	10	mwe	_	_
stage	NN	B-NP	O	Other	Other	###	12	stage	stage	NN	NN	_	9	nmod	_	_
in	IN	B-PP	O	Other	Other	###	13	in	in	IN	IN	_	15	case	_	_
selected	VBN	B-NP	O	Other	Other	###	14	selected	selected	VBN	VBN	_	15	amod	_	_
instances	NNS	I-NP	O	Other	Other	###	15	instances	instances	NNS	NNS	_	12	nmod	_	_
.	.	O	O	Other	Other	###	16	.	.	.	.	_	4	punct	_	_

To	TO	B-VP	O	Other	Other	###	1	To	To	TO	TO	_	3	mark	_	_
further	RB	I-VP	O	Other	Other	###	2	further	further	RB	RB	_	3	advmod	_	_
characterize	VB	I-VP	O	Other	Other	###	3	characterize	characterize	VB	VB	_	20	advcl	_	_
altered	JJ	B-NP	O	Other	Other	###	4	altered	altered	JJ	JJ	_	5	amod	_	_
expression	NN	I-NP	O	Other	Other	###	5	expression	expression	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	Other	###	6	of	of	IN	IN	_	7	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	7	TCRzeta	TCRzeta	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	Other	###	8	,	,	,	,	_	7	punct	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	9	p56(lck)	p56(lck)	NN	NN	_	7	appos	_	_
,	,	O	O	Other	Other	###	10	,	,	,	,	_	7	punct	_	_
and	CC	O	O	Other	Other	###	11	and	and	CC	CC	_	5	cc	_	_
impaired	JJ	B-NP	O	Other	Other	###	12	impaired	impaired	JJ	JJ	_	13	amod	_	_
activation	NN	I-NP	O	Other	Other	###	13	activation	activation	NN	NN	_	5	conj	_	_
of	IN	B-PP	O	Other	Other	###	14	of	of	IN	IN	_	15	case	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	15	NFkappaB	NFkappaB	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	Other	###	16	,	,	,	,	_	20	punct	_	_
T	NN	B-NP	B-cell_type	Other	Other	###	17	T	T	NN	NN	_	18	compound	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	Other	###	18	lymphocytes	lymphocytes	NNS	NNS	_	20	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	###	19	were	were	VBD	VBD	_	20	auxpass	_	_
obtained	VBN	I-VP	O	Other	Other	###	20	obtained	obtained	VBN	VBN	_	0	root	_	_
from	IN	B-PP	O	Other	Other	###	21	from	from	IN	IN	_	23	case	_	_
65	CD	B-NP	O	Other	Other	###	22	65	65	CD	CD	_	23	nummod	_	_
patients	NNS	I-NP	O	Other	Other	###	23	patients	patients	NNS	NNS	_	20	nmod	_	_
with	IN	B-PP	O	Other	Other	###	24	with	with	IN	IN	_	25	case	_	_
RCC	NN	B-NP	O	Other	Other	###	25	RCC	RCC	NN	NN	_	23	nmod	_	_
,	,	O	O	Other	Other	###	26	,	,	,	,	_	23	punct	_	_
the	DT	B-NP	O	Other	Other	###	27	the	the	DT	DT	_	28	det	_	_
majority	NN	I-NP	O	Other	Other	###	28	majority	majority	NN	NN	_	32	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	29	of	of	IN	IN	_	30	case	_	_
whom	WP	B-NP	O	Other	Other	###	30	whom	whom	WP	WP	_	28	nmod	_	_
were	VBD	B-VP	O	Other	Other	###	31	were	were	VBD	VBD	_	32	aux	_	_
receiving	VBG	I-VP	O	Other	Other	###	32	receiving	receiving	VBG	VBG	_	23	acl:relcl	_	_
combination	NN	B-NP	O	Other	Other	###	33	combination	combination	NN	NN	_	35	compound	_	_
cytokine	NN	I-NP	B-protein	Other	Other	###	34	cytokine	cytokine	NN	NN	_	35	compound	_	_
therapy	NN	I-NP	O	Other	Other	###	35	therapy	therapy	NN	NN	_	32	dobj	_	_
[	(	O	O	Other	Other	###	36	[	[	(	(	_	23	acl:relcl	_	_
interleukin	NN	I-NP	I-protein	B-Protein	Other	###	37	interleukin	interleukin	NN	NN	_	38	compound	_	_
(IL)-2	NN	I-NP	I-protein	I-Protein	Other	###	38	(IL)-2	(IL)-2	NN	NN	_	36	dobj	_	_
,	,	O	O	Other	Other	###	39	,	,	,	,	_	38	punct	_	_
IFN	NN	B-NP	B-protein	B-Protein	Other	###	40	IFN	IFN	NN	NN	_	41	compound	_	_
alpha	NN	B-NP	B-protein	I-Protein	Other	###	41	alpha	alpha	NN	NN	_	38	appos	_	_
-	-	O	O	Other	Other	###	42	-	-	-	-	_	41	punct	_	_
containing	NN	B-NP	O	Other	Other	###	43	containing	containing	NN	NN	_	41	acl	_	_
regimens	NNS	I-NP	O	Other	Other	###	44	regimens	regimens	NNS	NNS	_	43	dobj	_	_
]	)	O	O	Other	Other	###	45	]	]	)	)	_	38	nummod	_	_
and	CC	O	O	Other	Other	###	46	and	and	CC	CC	_	38	cc	_	_
37	CD	B-NP	O	Other	Other	###	47	37	37	CD	CD	_	49	nummod	_	_
control	JJ	I-NP	O	Other	Other	###	48	control	control	JJ	JJ	_	49	amod	_	_
individuals	NNS	I-NP	O	Other	Other	###	49	individuals	individuals	NNS	NNS	_	38	conj	_	_
.	.	O	O	Other	Other	###	50	.	.	.	.	_	20	punct	_	_

In	IN	B-PP	O	Other	Other	###	1	In	In	IN	IN	_	2	case	_	_
29	CD	B-NP	O	Other	Other	###	2	29	29	CD	CD	_	13	nmod	_	_
of	IN	B-PP	O	Other	Other	###	3	of	of	IN	IN	_	5	case	_	_
these	DT	B-NP	O	Other	Other	###	4	these	these	DT	DT	_	5	det	_	_
patients	NNS	I-NP	O	Other	Other	###	5	patients	patients	NNS	NNS	_	2	nmod	_	_
,	,	O	O	Other	Other	###	6	,	,	,	,	_	13	punct	_	_
levels	NNS	B-NP	O	Other	Other	###	7	levels	levels	NNS	NNS	_	13	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	9	TCRzeta	TCRzeta	NN	NN	_	7	nmod	_	_
and	CC	O	O	Other	Other	###	10	and	and	CC	CC	_	9	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	11	p56(lck)	p56(lck)	NN	NN	_	9	conj	_	_
were	VBD	B-VP	O	Other	Other	###	12	were	were	VBD	VBD	_	13	auxpass	_	_
determined	VBN	I-VP	O	Other	Other	###	13	determined	determined	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	Other	###	14	by	by	IN	IN	_	16	case	_	_
Western	JJ	B-NP	O	Other	Other	###	15	Western	Western	JJ	JJ	_	16	amod	_	_
blots	NNS	I-NP	O	Other	Other	###	16	blots	blots	NNS	NNS	_	13	nmod	_	_
of	IN	B-PP	O	Other	Other	###	17	of	of	IN	IN	_	19	case	_	_
T-cell	NN	B-NP	O	Other	Other	###	18	T-cell	T-cell	NN	NN	_	19	compound	_	_
lysates	NNS	I-NP	O	Other	Other	###	19	lysates	lysates	NNS	NNS	_	16	nmod	_	_
and	CC	O	O	Other	Other	###	20	and	and	CC	CC	_	13	cc	_	_
semiquantitated	VBN	B-VP	O	Other	Other	###	21	semiquantitated	semiquantitated	VBN	VBN	_	13	conj	_	_
using	VBG	B-VP	O	Other	Other	###	22	using	using	VBG	VBG	_	21	xcomp	_	_
densitometry	NN	B-NP	O	Other	Other	###	23	densitometry	densitometry	NN	NN	_	22	dobj	_	_
.	.	O	O	Other	Other	###	24	.	.	.	.	_	13	punct	_	_

Relative	JJ	B-NP	O	Other	Other	###	1	Relative	Relative	JJ	JJ	_	2	amod	_	_
levels	NNS	I-NP	O	Other	Other	###	2	levels	levels	NNS	NNS	_	5	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	###	3	were	were	VBD	VBD	_	5	auxpass	_	_
then	RB	I-VP	O	Other	Other	###	4	then	then	RB	RB	_	5	advmod	_	_
correlated	VBN	I-VP	O	Other	Other	###	5	correlated	correlated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	Other	###	6	with	with	IN	IN	_	8	case	_	_
a	DT	B-NP	O	Other	Other	###	7	a	a	DT	DT	_	8	det	_	_
series	NN	I-NP	O	Other	Other	###	8	series	series	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	Other	###	9	of	of	IN	IN	_	11	case	_	_
clinical	JJ	B-NP	O	Other	Other	###	10	clinical	clinical	JJ	JJ	_	11	amod	_	_
variables	NNS	I-NP	O	Other	Other	###	11	variables	variables	NNS	NNS	_	8	nmod	_	_
including	VBG	B-PP	O	Other	Other	###	12	including	including	VBG	VBG	_	13	case	_	_
response	NN	B-NP	O	Other	Other	###	13	response	response	NN	NN	_	11	nmod	_	_
to	TO	B-PP	O	Other	Other	###	14	to	to	TO	TO	_	15	case	_	_
therapy	NN	B-NP	O	Other	Other	###	15	therapy	therapy	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	Other	###	16	,	,	,	,	_	13	punct	_	_
performance	NN	B-NP	O	Other	Other	###	17	performance	performance	NN	NN	_	18	compound	_	_
status	NN	I-NP	O	Other	Other	###	18	status	status	NN	NN	_	13	conj	_	_
,	,	O	O	Other	Other	###	19	,	,	,	,	_	13	punct	_	_
survival	NN	B-NP	O	Other	Other	###	20	survival	survival	NN	NN	_	13	conj	_	_
,	,	O	O	Other	Other	###	21	,	,	,	,	_	13	punct	_	_
disease	NN	B-NP	O	Other	Other	###	22	disease	disease	NN	NN	_	23	compound	_	_
sites	NNS	I-NP	O	Other	Other	###	23	sites	sites	NNS	NNS	_	13	conj	_	_
,	,	O	O	Other	Other	###	24	,	,	,	,	_	13	punct	_	_
age	NN	B-NP	O	Other	Other	###	25	age	age	NN	NN	_	13	conj	_	_
,	,	O	O	Other	Other	###	26	,	,	,	,	_	13	punct	_	_
and	CC	O	O	Other	Other	###	27	and	and	CC	CC	_	13	cc	_	_
others	NNS	B-NP	O	Other	Other	###	28	others	others	NNS	NNS	_	13	conj	_	_
.	.	O	O	Other	Other	###	29	.	.	.	.	_	5	punct	_	_

In	IN	B-PP	O	Other	Other	###	1	In	In	IN	IN	_	3	case	_	_
another	DT	B-NP	O	Other	Other	###	2	another	another	DT	DT	_	3	det	_	_
group	NN	I-NP	O	Other	Other	###	3	group	group	NN	NN	_	23	nmod	_	_
of	IN	B-PP	O	Other	Other	###	4	of	of	IN	IN	_	6	case	_	_
28	CD	B-NP	O	Other	Other	###	5	28	28	CD	CD	_	6	nummod	_	_
patients	NNS	I-NP	O	Other	Other	###	6	patients	patients	NNS	NNS	_	3	nmod	_	_
(	(	O	O	Other	Other	###	7	(	(	(	(	_	9	punct	_	_
three	CD	B-NP	O	Other	Other	###	8	three	three	CD	CD	_	9	nummod	_	_
individuals	NNS	I-NP	O	Other	Other	###	9	individuals	individuals	NNS	NNS	_	6	dep	_	_
from	IN	B-PP	O	Other	Other	###	10	from	from	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	Other	###	11	the	the	DT	DT	_	13	det	_	_
first	JJ	I-NP	O	Other	Other	###	12	first	first	JJ	JJ	_	13	amod	_	_
group	NN	I-NP	O	Other	Other	###	13	group	group	NN	NN	_	9	nmod	_	_
)	)	O	O	Other	Other	###	14	)	)	)	)	_	9	punct	_	_
,	,	O	O	Other	Other	###	15	,	,	,	,	_	23	punct	_	_
the	DT	B-NP	O	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
frequency	NN	I-NP	O	Other	Other	###	17	frequency	frequency	NN	NN	_	23	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	18	of	of	IN	IN	_	21	case	_	_
abnormal	JJ	B-NP	O	Other	Other	###	19	abnormal	abnormal	JJ	JJ	_	21	amod	_	_
NFkappaB	NN	I-NP	B-protein	Other	Other	###	20	NFkappaB	NFkappaB	NN	NN	_	21	compound	_	_
activation	NN	I-NP	O	Other	Other	###	21	activation	activation	NN	NN	_	17	nmod	_	_
was	VBD	B-VP	O	Other	Other	###	22	was	was	VBD	VBD	_	23	auxpass	_	_
studied	VBN	I-VP	O	Other	Other	###	23	studied	studied	VBN	VBN	_	0	root	_	_
using	VBG	B-VP	O	Other	Other	###	24	using	using	VBG	VBG	_	23	xcomp	_	_
electrophoretic	JJ	B-NP	O	Other	Other	###	25	electrophoretic	electrophoretic	JJ	JJ	_	28	amod	_	_
mobility	NN	I-NP	O	Other	Other	###	26	mobility	mobility	NN	NN	_	28	compound	_	_
shift	NN	I-NP	O	Other	Other	###	27	shift	shift	NN	NN	_	28	compound	_	_
assays	NNS	I-NP	O	Other	Other	###	28	assays	assays	NNS	NNS	_	24	dobj	_	_
after	IN	B-PP	O	Other	Other	###	29	after	after	IN	IN	_	30	case	_	_
activation	NN	B-NP	O	Other	Other	###	30	activation	activation	NN	NN	_	24	nmod	_	_
of	IN	B-PP	O	Other	Other	###	31	of	of	IN	IN	_	33	case	_	_
T	NN	B-NP	B-cell_type	Other	Other	###	32	T	T	NN	NN	_	33	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	33	cells	cells	NNS	NNS	_	30	nmod	_	_
with	IN	B-PP	O	Other	Other	###	34	with	with	IN	IN	_	37	case	_	_
phorbol	NN	B-NP	O	Other	Other	###	35	phorbol	phorbol	NN	NN	_	37	compound	_	_
myristate	NN	I-NP	O	Other	Other	###	36	myristate	myristate	NN	NN	_	37	compound	_	_
acetate	NN	I-NP	O	Other	Other	###	37	acetate	acetate	NN	NN	_	30	nmod	_	_
/	/	O	O	Other	Other	###	38	/	/	/	/	_	37	punct	_	_
ionomycin	NN	I-NP	O	Other	Other	###	39	ionomycin	ionomycin	NN	NN	_	37	dep	_	_
or	CC	O	O	Other	Other	###	40	or	or	CC	CC	_	39	cc	_	_
anti-CD3	JJ	B-NP	B-protein	Other	Other	###	41	anti-CD3	anti-CD3	JJ	JJ	_	43	amod	_	_
monoclonal	JJ	I-NP	I-protein	Other	Other	###	42	monoclonal	monoclonal	JJ	JJ	_	43	amod	_	_
antibody	NN	I-NP	I-protein	Other	Other	###	43	antibody	antibody	NN	NN	_	39	conj	_	_
.	.	O	O	Other	Other	###	44	.	.	.	.	_	23	punct	_	_

Changes	NNS	B-NP	O	Other	Other	###	1	Changes	Changes	NNS	NNS	_	11	nsubjpass	_	_
in	IN	B-PP	O	Other	Other	###	2	in	in	IN	IN	_	5	case	_	_
these	DT	B-NP	O	Other	Other	###	3	these	these	DT	DT	_	5	det	_	_
signaling	VBG	I-NP	B-protein	Other	Other	###	4	signaling	signaling	VBG	VBG	_	5	amod	_	_
molecules	NNS	I-NP	I-protein	Other	Other	###	5	molecules	molecules	NNS	NNS	_	1	nmod	_	_
during	IN	B-PP	O	Other	Other	###	6	during	during	IN	IN	_	8	case	_	_
cytokine	NN	B-NP	B-protein	Other	Other	###	7	cytokine	cytokine	NN	NN	_	8	compound	_	_
treatment	NN	I-NP	O	Other	Other	###	8	treatment	treatment	NN	NN	_	1	nmod	_	_
were	VBD	B-VP	O	Other	Other	###	9	were	were	VBD	VBD	_	11	auxpass	_	_
also	RB	I-VP	O	Other	Other	###	10	also	also	RB	RB	_	11	advmod	_	_
investigated	VBN	I-VP	O	Other	Other	###	11	investigated	investigated	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	Other	###	12	.	.	.	.	_	11	punct	_	_

TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	1	TCRzeta	TCRzeta	NN	NN	_	5	nsubjpass	_	_
and	CC	I-NP	O	Other	Other	###	2	and	and	CC	CC	_	1	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	3	p56(lck)	p56(lck)	NN	NN	_	1	conj	_	_
were	VBD	B-VP	O	Other	Other	###	4	were	were	VBD	VBD	_	5	auxpass	_	_
detected	VBN	I-VP	O	Other	Other	###	5	detected	detected	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	6	in	in	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	Other	###	7	the	the	DT	DT	_	11	det	_	_
peripheral	JJ	I-NP	B-cell_type	Other	Other	###	8	peripheral	peripheral	JJ	JJ	_	11	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	###	9	blood	blood	NN	NN	_	11	compound	_	_
T	NN	I-NP	I-cell_type	Other	Other	###	10	T	T	NN	NN	_	11	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	11	cells	cells	NNS	NNS	_	5	nmod	_	_
in	IN	B-PP	O	Other	Other	###	12	in	in	IN	IN	_	16	case	_	_
27	CD	B-NP	O	Other	Other	###	13	27	27	CD	CD	_	15	compound	_	_
of	IN	B-PP	O	Other	Other	###	14	of	of	IN	IN	_	15	advmod	_	_
29	CD	B-NP	O	Other	Other	###	15	29	29	CD	CD	_	16	nummod	_	_
patients	NNS	I-NP	O	Other	Other	###	16	patients	patients	NNS	NNS	_	11	nmod	_	_
,	,	O	O	Other	Other	###	17	,	,	,	,	_	5	punct	_	_
and	CC	O	O	Other	Other	###	18	and	and	CC	CC	_	5	cc	_	_
overall	RB	B-ADVP	O	Other	Other	###	19	overall	overall	RB	RB	_	24	advmod	_	_
,	,	O	O	Other	Other	###	20	,	,	,	,	_	24	punct	_	_
reduced	VBN	B-NP	O	Other	Other	###	21	reduced	reduced	VBN	VBN	_	22	amod	_	_
levels	NNS	I-NP	O	Other	Other	###	22	levels	levels	NNS	NNS	_	24	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	###	23	were	were	VBD	VBD	_	24	auxpass	_	_
noted	VBN	I-VP	O	Other	Other	###	24	noted	noted	VBN	VBN	_	5	conj	_	_
visually	RB	B-ADVP	O	Other	Other	###	25	visually	visually	RB	RB	_	24	advmod	_	_
in	IN	B-PP	O	Other	Other	###	26	in	in	IN	IN	_	42	case	_	_
12	CD	B-NP	O	Other	Other	###	27	12	12	CD	CD	_	29	compound	_	_
of	IN	B-PP	O	Other	Other	###	28	of	of	IN	IN	_	29	advmod	_	_
29	CD	B-NP	O	Other	Other	###	29	29	29	CD	CD	_	42	nummod	_	_
(	(	O	O	Other	Other	###	30	(	(	(	(	_	32	punct	_	_
41	CD	B-NP	O	Other	Other	###	31	41	41	CD	CD	_	32	nummod	_	_
%	NN	I-NP	O	Other	Other	###	32	%	%	NN	NN	_	29	dep	_	_
)	)	O	O	Other	Other	###	33	)	)	)	)	_	32	punct	_	_
and	CC	O	O	Other	Other	###	34	and	and	CC	CC	_	29	cc	_	_
13	CD	B-NP	O	Other	Other	###	35	13	13	CD	CD	_	37	compound	_	_
of	IN	B-PP	O	Other	Other	###	36	of	of	IN	IN	_	37	advmod	_	_
29	CD	B-NP	O	Other	Other	###	37	29	29	CD	CD	_	29	conj	_	_
(	(	O	O	Other	Other	###	38	(	(	(	(	_	40	punct	_	_
45	CD	B-NP	O	Other	Other	###	39	45	45	CD	CD	_	40	nummod	_	_
%	NN	I-NP	O	Other	Other	###	40	%	%	NN	NN	_	37	dep	_	_
)	)	O	O	Other	Other	###	41	)	)	)	)	_	40	punct	_	_
individuals	NNS	B-NP	O	Other	Other	###	42	individuals	individuals	NNS	NNS	_	24	nmod	_	_
,	,	O	O	Other	Other	###	43	,	,	,	,	_	24	punct	_	_
respectively	RB	B-ADVP	O	Other	Other	###	44	respectively	respectively	RB	RB	_	24	advmod	_	_
.	.	O	O	Other	Other	###	45	.	.	.	.	_	5	punct	_	_

When	WRB	B-ADVP	O	Other	Other	###	1	When	When	WRB	WRB	_	4	advmod	_	_
levels	NNS	B-NP	O	Other	Other	###	2	levels	levels	NNS	NNS	_	4	nsubjpass	_	_
were	VBD	B-VP	O	Other	Other	###	3	were	were	VBD	VBD	_	4	auxpass	_	_
semiquantitated	VBN	I-VP	O	Other	Other	###	4	semiquantitated	semiquantitated	VBN	VBN	_	39	advcl	_	_
using	VBG	B-VP	O	Other	Other	###	5	using	using	VBG	VBG	_	4	xcomp	_	_
densitometry	NN	B-NP	O	Other	Other	###	6	densitometry	densitometry	NN	NN	_	5	dobj	_	_
,	,	O	O	Other	Other	###	7	,	,	,	,	_	39	punct	_	_
significant	JJ	B-NP	O	Other	Other	###	8	significant	significant	JJ	JJ	_	9	amod	_	_
decreases	NNS	I-NP	O	Other	Other	###	9	decreases	decreases	NNS	NNS	_	39	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	10	of	of	IN	IN	_	11	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	11	TCRzeta	TCRzeta	NN	NN	_	9	nmod	_	_
(	(	O	O	Other	Other	###	12	(	(	(	(	_	14	punct	_	_
P	NN	B-NP	O	Other	Other	###	13	P	P	NN	NN	_	14	nsubj	_	_
=	SYM	B-VP	O	Other	Other	###	14	=	=	SYM	SYM	_	11	dep	_	_
0.029	CD	B-NP	O	Other	Other	###	15	0.029	0.029	CD	CD	_	14	dobj	_	_
)	)	O	O	Other	Other	###	16	)	)	)	)	_	14	punct	_	_
and	CC	O	O	Other	Other	###	17	and	and	CC	CC	_	11	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	18	p56(lck)	p56(lck)	NN	NN	_	11	conj	_	_
(	(	O	O	Other	Other	###	19	(	(	(	(	_	21	punct	_	_
P	NN	B-NP	O	Other	Other	###	20	P	P	NN	NN	_	21	nsubj	_	_
=	SYM	B-VP	O	Other	Other	###	21	=	=	SYM	SYM	_	18	dep	_	_
0.029	CD	B-NP	O	Other	Other	###	22	0.029	0.029	CD	CD	_	21	dobj	_	_
)	)	O	O	Other	Other	###	23	)	)	)	)	_	21	punct	_	_
but	CC	B-NP	O	Other	Other	###	24	but	but	CC	CC	_	25	cc	_	_
not	RB	I-NP	O	Other	Other	###	25	not	not	RB	RB	_	11	cc	_	_
CD3epsilon	NN	B-NP	B-protein	B-Protein	Other	###	26	CD3epsilon	CD3epsilon	NN	NN	_	11	conj	_	_
(	(	O	O	Other	Other	###	27	(	(	(	(	_	29	punct	_	_
P	NN	B-NP	O	Other	Other	###	28	P	P	NN	NN	_	29	nsubj	_	_
=	SYM	B-VP	O	Other	Other	###	29	=	=	SYM	SYM	_	26	dep	_	_
0.131	CD	B-NP	O	Other	Other	###	30	0.131	0.131	CD	CD	_	29	dobj	_	_
)	)	O	O	Other	Other	###	31	)	)	)	)	_	29	punct	_	_
,	,	O	O	Other	Other	###	32	,	,	,	,	_	39	punct	_	_
compared	VBN	B-PP	O	Other	Other	###	33	compared	compared	VBN	VBN	_	36	case	_	_
with	IN	B-PP	O	Other	Other	###	34	with	with	IN	IN	_	36	case	_	_
control	NN	B-NP	O	Other	Other	###	35	control	control	NN	NN	_	36	compound	_	_
levels	NNS	I-NP	O	Other	Other	###	36	levels	levels	NNS	NNS	_	39	advcl	_	_
,	,	O	O	Other	Other	###	37	,	,	,	,	_	39	punct	_	_
were	VBD	B-VP	O	Other	Other	###	38	were	were	VBD	VBD	_	39	auxpass	_	_
found	VBN	I-VP	O	Other	Other	###	39	found	found	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	Other	###	40	.	.	.	.	_	39	punct	_	_

In	IN	B-PP	O	Other	Other	###	1	In	In	IN	IN	_	2	case	_	_
patients	NNS	B-NP	O	Other	Other	###	2	patients	patients	NNS	NNS	_	17	nmod	_	_
treated	VBN	B-VP	O	Other	Other	###	3	treated	treated	VBN	VBN	_	2	acl	_	_
with	IN	B-PP	O	Other	Other	###	4	with	with	IN	IN	_	11	case	_	_
IL-2	NN	B-NP	B-protein	B-Protein	Other	###	5	IL-2	IL-2	NN	NN	_	11	compound	_	_
/	/	O	O	Other	Other	###	6	/	/	/	/	_	5	punct	_	_
IFN	NN	B-NP	B-protein	B-Protein	Other	###	7	IFN	IFN	NN	NN	_	8	compound	_	_
alpha	NN	B-NP	B-protein	I-Protein	Other	###	8	alpha	alpha	NN	NN	_	5	dep	_	_
-	-	O	O	Other	Other	###	9	-	-	-	-	_	8	punct	_	_
based	NN	B-NP	O	Other	Other	###	10	based	based	NN	NN	_	11	compound	_	_
therapy	NN	I-NP	O	Other	Other	###	11	therapy	therapy	NN	NN	_	3	nmod	_	_
,	,	O	O	Other	Other	###	12	,	,	,	,	_	17	punct	_	_
relative	JJ	B-NP	O	Other	Other	###	13	relative	relative	JJ	JJ	_	14	amod	_	_
levels	NNS	I-NP	O	Other	Other	###	14	levels	levels	NNS	NNS	_	17	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	16	TCRzeta	TCRzeta	NN	NN	_	14	nmod	_	_
increased	VBD	B-VP	O	Other	Other	###	17	increased	increased	VBD	VBD	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	Other	###	18	significantly	significantly	RB	RB	_	17	advmod	_	_
(	(	O	O	Other	Other	###	19	(	(	(	(	_	21	punct	_	_
P	NN	B-NP	O	Other	Other	###	20	P	P	NN	NN	_	21	nsubj	_	_
=	SYM	B-VP	O	Other	Other	###	21	=	=	SYM	SYM	_	17	parataxis	_	_
0.002	CD	B-NP	O	Other	Other	###	22	0.002	0.002	CD	CD	_	21	dobj	_	_
)	)	O	O	Other	Other	###	23	)	)	)	)	_	21	punct	_	_
on	IN	B-PP	O	Other	Other	###	24	on	on	IN	IN	_	25	case	_	_
day	NN	B-NP	O	Other	Other	###	25	day	day	NN	NN	_	17	nmod	_	_
15	CD	I-NP	O	Other	Other	###	26	15	15	CD	CD	_	25	nummod	_	_
of	IN	B-PP	O	Other	Other	###	27	of	of	IN	IN	_	28	case	_	_
cycle	NN	B-NP	O	Other	Other	###	28	cycle	cycle	NN	NN	_	25	nmod	_	_
one	CD	I-NP	O	Other	Other	###	29	one	one	CD	CD	_	28	nummod	_	_
compared	VBN	B-PP	O	Other	Other	###	30	compared	compared	VBN	VBN	_	33	case	_	_
with	IN	B-PP	O	Other	Other	###	31	with	with	IN	IN	_	33	case	_	_
the	DT	B-NP	O	Other	Other	###	32	the	the	DT	DT	_	33	det	_	_
baseline	NN	I-NP	O	Other	Other	###	33	baseline	baseline	NN	NN	_	17	advcl	_	_
.	.	O	O	Other	Other	###	34	.	.	.	.	_	17	punct	_	_

Correlations	NNS	B-NP	O	Other	Other	###	1	Correlations	Correlations	NNS	NNS	_	32	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	2	of	of	IN	IN	_	6	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	3	TCRzeta	TCRzeta	NN	NN	_	6	compound	_	_
or	CC	O	O	Other	Other	###	4	or	or	CC	CC	_	3	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	5	p56(lck)	p56(lck)	NN	NN	_	3	conj	_	_
levels	NNS	B-NP	O	Other	Other	###	6	levels	levels	NNS	NNS	_	1	nmod	_	_
with	IN	B-PP	O	Other	Other	###	7	with	with	IN	IN	_	11	case	_	_
response	NN	B-NP	O	Other	Other	###	8	response	response	NN	NN	_	11	compound	_	_
or	CC	I-NP	O	Other	Other	###	9	or	or	CC	CC	_	8	cc	_	_
disease	NN	I-NP	O	Other	Other	###	10	disease	disease	NN	NN	_	8	conj	_	_
variables	NNS	I-NP	O	Other	Other	###	11	variables	variables	NNS	NNS	_	1	nmod	_	_
,	,	O	O	Other	Other	###	12	,	,	,	,	_	1	punct	_	_
except	IN	B-PP	O	Other	Other	###	13	except	except	IN	IN	_	17	case	_	_
for	IN	B-PP	O	Other	Other	###	14	for	for	IN	IN	_	17	case	_	_
lower	JJR	B-NP	O	Other	Other	###	15	lower	lower	JJR	JJR	_	17	amod	_	_
TCRzeta	NN	I-NP	B-protein	B-Protein	B-Protein	###	16	TCRzeta	TCRzeta	NN	NN	_	17	compound	_	_
levels	NNS	I-NP	O	Other	Other	###	17	levels	levels	NNS	NNS	_	1	nmod	_	_
(	(	O	O	Other	Other	###	18	(	(	(	(	_	20	punct	_	_
P	NN	B-NP	O	Other	Other	###	19	P	P	NN	NN	_	20	compound	_	_
<	SYM	O	O	Other	Other	###	20	<	<	SYM	SYM	_	21	amod	_	_
0.001	CD	B-NP	O	Other	Other	###	21	0.001	0.001	CD	CD	_	17	appos	_	_
)	)	O	O	Other	Other	###	22	)	)	)	)	_	20	punct	_	_
in	IN	B-PP	O	Other	Other	###	23	in	in	IN	IN	_	28	case	_	_
the	DT	I-PP	O	Other	Other	###	24	the	the	DT	DT	_	28	dep	_	_
presence	NN	I-PP	O	Other	Other	###	25	presence	presence	NN	NN	_	28	dep	_	_
of	IN	I-PP	O	Other	Other	###	26	of	of	IN	IN	_	28	case	_	_
bone	NN	B-NP	B-protein	Other	Other	###	27	bone	bone	NN	NN	_	28	compound	_	_
metastases	NNS	I-NP	I-protein	Other	Other	###	28	metastases	metastases	NNS	NNS	_	17	nmod	_	_
,	,	O	O	Other	Other	###	29	,	,	,	,	_	1	punct	_	_
were	VBD	B-VP	O	Other	Other	###	30	were	were	VBD	VBD	_	32	auxpass	_	_
not	RB	I-VP	O	Other	Other	###	31	not	not	RB	RB	_	32	neg	_	_
found	VBN	I-VP	O	Other	Other	###	32	found	found	VBN	VBN	_	0	root	_	_
.	.	O	O	Other	Other	###	33	.	.	.	.	_	32	punct	_	_

Abnormal	JJ	B-NP	O	Other	Other	###	1	Abnormal	Abnormal	JJ	JJ	_	3	amod	_	_
NFkappaB	NN	I-NP	B-protein	Other	Other	###	2	NFkappaB	NFkappaB	NN	NN	_	3	compound	_	_
activation	NN	I-NP	O	Other	Other	###	3	activation	activation	NN	NN	_	19	nsubjpass	_	_
after	IN	B-PP	O	Other	Other	###	4	after	after	IN	IN	_	5	case	_	_
stimulation	NN	B-NP	O	Other	Other	###	5	stimulation	stimulation	NN	NN	_	3	nmod	_	_
with	IN	B-PP	O	Other	Other	###	6	with	with	IN	IN	_	9	case	_	_
phorbol	NN	B-NP	O	Other	Other	###	7	phorbol	phorbol	NN	NN	_	9	compound	_	_
myristate	NN	I-NP	O	Other	Other	###	8	myristate	myristate	NN	NN	_	9	compound	_	_
acetate	NN	I-NP	O	Other	Other	###	9	acetate	acetate	NN	NN	_	5	nmod	_	_
/	/	O	O	Other	Other	###	10	/	/	/	/	_	9	punct	_	_
ionomycin	NN	I-NP	O	Other	Other	###	11	ionomycin	ionomycin	NN	NN	_	9	dep	_	_
and	CC	O	O	Other	Other	###	12	and	and	CC	CC	_	11	cc	_	_
/	/	O	O	Other	Other	###	13	/	/	/	/	_	11	punct	_	_
or	CC	O	O	Other	Other	###	14	or	or	CC	CC	_	9	cc	_	_
anti-CD3	JJ	B-NP	B-protein	Other	Other	###	15	anti-CD3	anti-CD3	JJ	JJ	_	17	amod	_	_
monoclonal	JJ	I-NP	I-protein	Other	Other	###	16	monoclonal	monoclonal	JJ	JJ	_	17	amod	_	_
antibody	NN	I-NP	I-protein	Other	Other	###	17	antibody	antibody	NN	NN	_	9	conj	_	_
was	VBD	B-VP	O	Other	Other	###	18	was	was	VBD	VBD	_	19	auxpass	_	_
found	VBN	I-VP	O	Other	Other	###	19	found	found	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	20	in	in	IN	IN	_	22	case	_	_
59	CD	B-NP	O	Other	Other	###	21	59	59	CD	CD	_	22	nummod	_	_
%	NN	I-NP	O	Other	Other	###	22	%	%	NN	NN	_	19	nmod	_	_
of	IN	B-PP	O	Other	Other	###	23	of	of	IN	IN	_	24	case	_	_
patients	NNS	B-NP	O	Other	Other	###	24	patients	patients	NNS	NNS	_	22	nmod	_	_
(	(	O	O	Other	Other	###	25	(	(	(	(	_	28	punct	_	_
17	CD	B-NP	O	Other	Other	###	26	17	17	CD	CD	_	28	compound	_	_
of	IN	B-PP	O	Other	Other	###	27	of	of	IN	IN	_	28	advmod	_	_
28	CD	B-NP	O	Other	Other	###	28	28	28	CD	CD	_	22	dep	_	_
)	)	O	O	Other	Other	###	29	)	)	)	)	_	28	punct	_	_
and	CC	O	O	Other	Other	###	30	and	and	CC	CC	_	19	cc	_	_
was	VBD	B-VP	O	Other	Other	###	31	was	was	VBD	VBD	_	33	auxpass	_	_
not	RB	I-VP	O	Other	Other	###	32	not	not	RB	RB	_	33	neg	_	_
accounted	VBN	I-VP	O	Other	Other	###	33	accounted	accounted	VBN	VBN	_	19	conj	_	_
for	IN	B-PP	O	Other	Other	###	34	for	for	IN	IN	_	33	nmod	_	_
by	IN	B-PP	O	Other	Other	###	35	by	by	IN	IN	_	38	case	_	_
the	DT	B-NP	O	Other	Other	###	36	the	the	DT	DT	_	38	det	_	_
advanced	JJ	I-NP	O	Other	Other	###	37	advanced	advanced	JJ	JJ	_	38	amod	_	_
age	NN	I-NP	O	Other	Other	###	38	age	age	NN	NN	_	33	nmod	_	_
of	IN	B-PP	O	Other	Other	###	39	of	of	IN	IN	_	42	case	_	_
the	DT	B-NP	O	Other	Other	###	40	the	the	DT	DT	_	42	det	_	_
study	NN	I-NP	O	Other	Other	###	41	study	study	NN	NN	_	42	compound	_	_
cohort	NN	I-NP	O	Other	Other	###	42	cohort	cohort	NN	NN	_	38	nmod	_	_
.	.	O	O	Other	Other	###	43	.	.	.	.	_	19	punct	_	_

Activation	NN	B-NP	O	Other	Other	###	1	Activation	Activation	NN	NN	_	10	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	2	of	of	IN	IN	_	3	case	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	3	NFkappaB	NFkappaB	NN	NN	_	1	nmod	_	_
in	IN	B-PP	O	Other	Other	###	4	in	in	IN	IN	_	8	case	_	_
peripheral	JJ	B-NP	B-cell_type	Other	Other	###	5	peripheral	peripheral	JJ	JJ	_	8	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	###	6	blood	blood	NN	NN	_	8	compound	_	_
T	NN	I-NP	I-cell_type	Other	Other	###	7	T	T	NN	NN	_	8	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	8	cells	cells	NNS	NNS	_	1	nmod	_	_
was	VBD	B-VP	O	Other	Other	###	9	was	was	VBD	VBD	_	10	cop	_	_
inducible	JJ	B-ADJP	O	Other	Other	###	10	inducible	inducible	JJ	JJ	_	0	root	_	_
during	IN	B-PP	O	Other	Other	###	11	during	during	IN	IN	_	13	case	_	_
cytokine	NN	B-NP	B-protein	Other	Other	###	12	cytokine	cytokine	NN	NN	_	13	compound	_	_
therapy	NN	I-NP	O	Other	Other	###	13	therapy	therapy	NN	NN	_	10	nmod	_	_
in	IN	B-PP	O	Other	Other	###	14	in	in	IN	IN	_	18	case	_	_
four	CD	B-NP	O	Other	Other	###	15	four	four	CD	CD	_	17	compound	_	_
of	IN	I-NP	O	Other	Other	###	16	of	of	IN	IN	_	17	advmod	_	_
six	CD	I-NP	O	Other	Other	###	17	six	six	CD	CD	_	18	nummod	_	_
individuals	NNS	I-NP	O	Other	Other	###	18	individuals	individuals	NNS	NNS	_	13	nmod	_	_
who	WP	B-NP	O	Other	Other	###	19	who	who	WP	WP	_	20	nsubj	_	_
displayed	VBD	B-VP	O	Other	Other	###	20	displayed	displayed	VBD	VBD	_	18	acl:relcl	_	_
impaired	JJ	B-NP	O	Other	Other	###	21	impaired	impaired	JJ	JJ	_	23	amod	_	_
NFkappaB	NN	I-NP	B-protein	Other	Other	###	22	NFkappaB	NFkappaB	NN	NN	_	23	compound	_	_
activity	NN	I-NP	O	Other	Other	###	23	activity	activity	NN	NN	_	20	dobj	_	_
prior	RB	B-ADVP	O	Other	Other	###	24	prior	prior	RB	RB	_	26	case	_	_
to	TO	B-PP	O	Other	Other	###	25	to	to	TO	TO	_	24	mwe	_	_
therapy	NN	B-NP	O	Other	Other	###	26	therapy	therapy	NN	NN	_	20	nmod	_	_
.	.	O	O	Other	Other	###	27	.	.	.	.	_	10	punct	_	_

Moreover	RB	B-ADVP	O	Other	Other	###	1	Moreover	Moreover	RB	RB	_	9	advmod	_	_
,	,	O	O	Other	Other	###	2	,	,	,	,	_	9	punct	_	_
impaired	JJ	B-NP	O	Other	Other	###	3	impaired	impaired	JJ	JJ	_	4	amod	_	_
activation	NN	I-NP	O	Other	Other	###	4	activation	activation	NN	NN	_	9	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	5	of	of	IN	IN	_	6	case	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	6	NFkappaB	NFkappaB	NN	NN	_	4	nmod	_	_
does	VBZ	B-VP	O	Other	Other	###	7	does	does	VBZ	VBZ	_	9	aux	_	_
not	RB	I-VP	O	Other	Other	###	8	not	not	RB	RB	_	9	neg	_	_
appear	VB	I-VP	O	Other	Other	###	9	appear	appear	VB	VB	_	0	root	_	_
linked	VBN	I-VP	O	Other	Other	###	10	linked	linked	VBN	VBN	_	9	xcomp	_	_
to	TO	B-PP	O	Other	Other	###	11	to	to	TO	TO	_	13	case	_	_
a	DT	B-NP	O	Other	Other	###	12	a	a	DT	DT	_	13	det	_	_
reduction	NN	I-NP	O	Other	Other	###	13	reduction	reduction	NN	NN	_	10	nmod	_	_
of	IN	B-PP	O	Other	Other	###	14	of	of	IN	IN	_	16	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	15	TCRzeta	TCRzeta	NN	NN	_	16	compound	_	_
expression	NN	I-NP	O	Other	Other	###	16	expression	expression	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	Other	###	17	,	,	,	,	_	9	punct	_	_
because	IN	B-SBAR	O	Other	Other	###	18	because	because	IN	IN	_	27	mark	_	_
in	IN	B-PP	O	Other	Other	###	19	in	in	IN	IN	_	21	case	_	_
five	CD	B-NP	O	Other	Other	###	20	five	five	CD	CD	_	21	nummod	_	_
patients	NNS	I-NP	O	Other	Other	###	21	patients	patients	NNS	NNS	_	27	nmod	_	_
,	,	O	O	Other	Other	###	22	,	,	,	,	_	27	punct	_	_
normal	JJ	B-NP	O	Other	Other	###	23	normal	normal	JJ	JJ	_	25	amod	_	_
TCRzeta	NN	I-NP	B-protein	B-Protein	B-Protein	###	24	TCRzeta	TCRzeta	NN	NN	_	25	compound	_	_
levels	NNS	I-NP	O	Other	Other	###	25	levels	levels	NNS	NNS	_	27	nsubj	_	_
were	VBD	B-VP	O	Other	Other	###	26	were	were	VBD	VBD	_	27	cop	_	_
present	JJ	B-ADJP	O	Other	Other	###	27	present	present	JJ	JJ	_	9	advcl	_	_
although	IN	B-SBAR	O	Other	Other	###	28	although	although	IN	IN	_	33	mark	_	_
kappaB	NN	B-NP	B-protein	Other	Other	###	29	kappaB	kappaB	NN	NN	_	30	compound	_	_
binding	NN	I-NP	O	Other	Other	###	30	binding	binding	NN	NN	_	33	nsubj	_	_
was	VBD	B-VP	O	Other	Other	###	31	was	was	VBD	VBD	_	33	cop	_	_
not	RB	O	O	Other	Other	###	32	not	not	RB	RB	_	33	neg	_	_
inducible	JJ	B-ADJP	O	Other	Other	###	33	inducible	inducible	JJ	JJ	_	27	advcl	_	_
.	.	O	O	Other	Other	###	34	.	.	.	.	_	9	punct	_	_

In	IN	B-PP	O	Other	Other	###	1	In	In	IN	IN	_	3	case	_	_
the	DT	B-NP	O	Other	Other	###	2	the	the	DT	DT	_	3	det	_	_
majority	NN	I-NP	O	Other	Other	###	3	majority	majority	NN	NN	_	14	nmod	_	_
of	IN	B-PP	O	Other	Other	###	4	of	of	IN	IN	_	5	case	_	_
patients	NNS	B-NP	O	Other	Other	###	5	patients	patients	NNS	NNS	_	3	nmod	_	_
with	IN	B-PP	O	Other	Other	###	6	with	with	IN	IN	_	8	case	_	_
advanced	VBN	B-NP	O	Other	Other	###	7	advanced	advanced	VBN	VBN	_	8	amod	_	_
RCC	NN	I-NP	O	Other	Other	###	8	RCC	RCC	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	Other	###	9	,	,	,	,	_	14	punct	_	_
peripheral	JJ	B-NP	B-cell_type	Other	Other	###	10	peripheral	peripheral	JJ	JJ	_	13	amod	_	_
blood	NN	I-NP	I-cell_type	Other	Other	###	11	blood	blood	NN	NN	_	13	compound	_	_
T	NN	I-NP	I-cell_type	Other	Other	###	12	T	T	NN	NN	_	13	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	Other	###	13	cells	cells	NNS	NNS	_	14	nsubj	_	_
express	VBP	B-VP	O	Other	Other	###	14	express	express	VBP	VBP	_	0	root	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	15	TCRzeta	TCRzeta	NN	NN	_	14	dobj	_	_
and	CC	O	O	Other	Other	###	16	and	and	CC	CC	_	15	cc	_	_
p56(lck)	NN	I-NP	I-protein	B-Protein	B-Protein	###	17	p56(lck)	p56(lck)	NN	NN	_	15	conj	_	_
,	,	O	O	Other	Other	###	18	,	,	,	,	_	14	punct	_	_
and	CC	O	O	Other	Other	###	19	and	and	CC	CC	_	14	cc	_	_
in	IN	B-PP	O	Other	Other	###	20	in	in	IN	IN	_	22	case	_	_
a	DT	B-NP	O	Other	Other	###	21	a	a	DT	DT	_	22	det	_	_
subset	NN	I-NP	O	Other	Other	###	22	subset	subset	NN	NN	_	32	nmod	_	_
,	,	O	O	Other	Other	###	23	,	,	,	,	_	32	punct	_	_
reduced	VBD	B-VP	O	Other	Other	###	24	reduced	reduced	VBD	VBD	_	25	amod	_	_
levels	NNS	B-NP	O	Other	Other	###	25	levels	levels	NNS	NNS	_	32	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	###	26	of	of	IN	IN	_	30	case	_	_
these	DT	B-NP	O	Other	Other	###	27	these	these	DT	DT	_	30	det	_	_
TCRzeta	NN	I-NP	B-protein	B-Protein	B-Protein	###	28	TCRzeta	TCRzeta	NN	NN	_	30	compound	_	_
associated	JJ	I-NP	I-protein	Other	Other	###	29	associated	associated	JJ	JJ	_	30	amod	_	_
molecules	NNS	I-NP	I-protein	Other	Other	###	30	molecules	molecules	NNS	NNS	_	25	nmod	_	_
are	VBP	B-VP	O	Other	Other	###	31	are	are	VBP	VBP	_	32	auxpass	_	_
seen	VBN	I-VP	O	Other	Other	###	32	seen	seen	VBN	VBN	_	14	conj	_	_
that	WDT	B-NP	O	Other	Other	###	33	that	that	WDT	WDT	_	35	nsubj	_	_
may	MD	B-VP	O	Other	Other	###	34	may	may	MD	MD	_	35	aux	_	_
increase	VB	I-VP	O	Other	Other	###	35	increase	increase	VB	VB	_	32	ccomp	_	_
during	IN	B-PP	O	Other	Other	###	36	during	during	IN	IN	_	38	case	_	_
cytokine-based	JJ	B-NP	O	Other	Other	###	37	cytokine-based	cytokine-based	JJ	JJ	_	38	amod	_	_
therapy	NN	I-NP	O	Other	Other	###	38	therapy	therapy	NN	NN	_	35	nmod	_	_
.	.	O	O	Other	Other	###	39	.	.	.	.	_	14	punct	_	_

Abnormal	JJ	B-NP	O	Other	Other	###	1	Abnormal	Abnormal	JJ	JJ	_	2	amod	_	_
activation	NN	I-NP	O	Other	Other	###	2	activation	activation	NN	NN	_	7	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	4	NFkappaB	NFkappaB	NN	NN	_	2	nmod	_	_
is	VBZ	B-VP	O	Other	Other	###	5	is	is	VBZ	VBZ	_	7	cop	_	_
also	RB	B-ADVP	O	Other	Other	###	6	also	also	RB	RB	_	7	advmod	_	_
present	JJ	B-ADJP	O	Other	Other	###	7	present	present	JJ	JJ	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	8	in	in	IN	IN	_	11	case	_	_
>	JJR	B-NP	O	Other	Other	###	9	>	>	JJR	JJR	_	10	advmod	_	_
50	CD	I-NP	O	Other	Other	###	10	50	50	CD	CD	_	11	nummod	_	_
%	NN	I-NP	O	Other	Other	###	11	%	%	NN	NN	_	7	nmod	_	_
of	IN	B-PP	O	Other	Other	###	12	of	of	IN	IN	_	13	case	_	_
patients	NNS	B-NP	O	Other	Other	###	13	patients	patients	NNS	NNS	_	11	nmod	_	_
and	CC	O	O	Other	Other	###	14	and	and	CC	CC	_	7	cc	_	_
may	MD	B-VP	O	Other	Other	###	15	may	may	MD	MD	_	17	aux	_	_
also	RB	I-VP	O	Other	Other	###	16	also	also	RB	RB	_	17	advmod	_	_
revert	VB	I-VP	O	Other	Other	###	17	revert	revert	VB	VB	_	7	conj	_	_
to	TO	B-PP	O	Other	Other	###	18	to	to	TO	TO	_	19	case	_	_
normal	JJ	B-ADJP	O	Other	Other	###	19	normal	normal	JJ	JJ	_	17	nmod	_	_
during	IN	B-PP	O	Other	Other	###	20	during	during	IN	IN	_	28	case	_	_
IL-2	NN	B-NP	B-protein	B-Protein	Other	###	21	IL-2	IL-2	NN	NN	_	28	compound	_	_
/	/	O	O	Other	Other	###	22	/	/	/	/	_	21	punct	_	_
I	NN	B-NP	O	Other	Other	###	23	I	I	NN	NN	_	25	compound	_	_
FN	NN	B-NP	B-protein	B-Protein	Other	###	24	FN	FN	NN	NN	_	25	compound	_	_
alpha	NN	B-NP	B-protein	I-Protein	Other	###	25	alpha	alpha	NN	NN	_	28	compound	_	_
-	-	O	O	Other	Other	###	26	-	-	-	-	_	25	punct	_	_
based	NN	O	O	Other	Other	###	27	based	based	NN	NN	_	28	amod	_	_
treatment	NN	I-NP	O	Other	Other	###	28	treatment	treatment	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	Other	###	29	.	.	.	.	_	7	punct	_	_

This	DT	B-NP	O	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
alteration	NN	I-NP	O	Other	Other	###	2	alteration	alteration	NN	NN	_	6	nsubj	_	_
in	IN	B-PP	O	Other	Other	###	3	in	in	IN	IN	_	5	case	_	_
NFkappaB	NN	B-NP	B-protein	Other	Other	###	4	NFkappaB	NFkappaB	NN	NN	_	5	compound	_	_
activation	NN	I-NP	O	Other	Other	###	5	activation	activation	NN	NN	_	2	nmod	_	_
occurred	VBD	B-VP	O	Other	Other	###	6	occurred	occurred	VBD	VBD	_	0	root	_	_
in	IN	B-PP	O	Other	Other	###	7	in	in	IN	IN	_	12	case	_	_
the	DT	B-NP	O	Other	Other	###	8	the	the	DT	DT	_	12	dep	_	_
presence	NN	I-NP	O	Other	Other	###	9	presence	presence	NN	NN	_	12	dep	_	_
of	IN	B-PP	O	Other	Other	###	10	of	of	IN	IN	_	12	case	_	_
normal	JJ	B-NP	O	Other	Other	###	11	normal	normal	JJ	JJ	_	12	amod	_	_
expression	NN	I-NP	O	Other	Other	###	12	expression	expression	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	Other	###	13	of	of	IN	IN	_	18	case	_	_
TCRzeta	NN	B-NP	B-protein	B-Protein	B-Protein	###	14	TCRzeta	TCRzeta	NN	NN	_	18	compound	_	_
-	-	O	O	Other	Other	###	15	-	-	-	-	_	18	punct	_	_
associated	NN	B-NP	O	Other	Other	###	16	associated	associated	NN	NN	_	18	amod	_	_
signaling	NN	I-NP	I-DNA	Other	Other	###	17	signaling	signaling	NN	NN	_	18	compound	_	_
elements	NNS	I-NP	I-DNA	Other	Other	###	18	elements	elements	NNS	NNS	_	12	nmod	_	_
.	.	O	O	Other	Other	###	19	.	.	.	.	_	6	punct	_	_

The	DT	B-NP	O	Other	Other	###	1	The	The	DT	DT	_	3	det	_	_
clinical	JJ	I-NP	O	Other	Other	###	2	clinical	clinical	JJ	JJ	_	3	amod	_	_
significance	NN	I-NP	O	Other	Other	###	3	significance	significance	NN	NN	_	7	nsubj	_	_
of	IN	B-PP	O	Other	Other	###	4	of	of	IN	IN	_	6	case	_	_
these	DT	B-NP	O	Other	Other	###	5	these	these	DT	DT	_	6	det	_	_
findings	NNS	I-NP	O	Other	Other	###	6	findings	findings	NNS	NNS	_	3	nmod	_	_
remains	VBZ	B-VP	O	Other	Other	###	7	remains	remains	VBZ	VBZ	_	0	root	_	_
unclear	JJ	B-ADJP	O	Other	Other	###	8	unclear	unclear	JJ	JJ	_	7	xcomp	_	_
.	.	O	O	Other	Other	###	9	.	.	.	.	_	7	punct	_	_

